NCT03697434

Brief Summary

This study will assess the feasibility of using specific criteria to standardize the referral of individuals with Parkinson disease to a group of medical providers known as palliative care specialists. Palliative care specialists provide supportive care to individuals living with serious illnesses. The specialty focuses on providing relief from the symptoms and stress of serious illness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Nov 2018

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 5, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

November 16, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 2, 2019

Completed
Last Updated

December 9, 2019

Status Verified

December 1, 2019

Enrollment Period

7 months

First QC Date

October 3, 2018

Last Update Submit

December 5, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of enrolled participants who have at least 1 visit with a palliative care provider within 3 months of referral

    We will assess the feasibility of standardized referral to palliative care by calculating the proportion of enrolled participants with Parkinson disease who have at least 1 visit with a palliative care provider within 3 months of referral.

    3 months

Secondary Outcomes (6)

  • Change in mean symptom burden

    Baseline to 3 months

  • Change in mean quality of life as assessed by the Quality of Life-Alzheimer Disease questionnaire (QoL-AD)

    Baseline to 3 months

  • Change in mean caregiver burden

    Baseline to 3 months

  • Change in mean caregiver self-efficacy

    Baseline to 3 months

  • Barriers to palliative care referral

    Baseline

  • +1 more secondary outcomes

Study Arms (1)

Palliative Care referral

EXPERIMENTAL

Participants with specific uncontrolled symptoms or critical events in course of their Parkinson disease will be referred to a palliative care specialist for supportive care.

Behavioral: Palliative Care referral

Interventions

Individuals with Parkinson disease identified as having specific uncontrolled symptoms or critical events will undergo standardized referral to palliative care, who will provide supportive care. During the palliative care referral, participants and their care partners may discuss symptoms, disease burden (physical, emotion, financial, and psychological), quality of life, goals of care, and advance directive completion. Palliative care specialists may recommend interventions to manage bothersome symptoms or to improve disease burden for both participants and care partners.

Palliative Care referral

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of idiopathic PD confirmed as most likely diagnosis with participant's treating provider
  • years of age or older
  • Participant or care partner able to provide informed consent
  • Presence of one or more of the following:
  • Uncontrolled symptoms (over prior week):
  • Depression
  • Pain
  • Fatigue
  • Critical events (over prior 6 months):
  • ≥3 falls
  • Unintended weight loss
  • Wheelchair dependence (\>50% of time)

You may not qualify if:

  • Diagnosis of atypical or secondary parkinsonism
  • Outpatient palliative care visit scheduled or within the prior 6 months of the screening visit
  • Subjects who are care partners:
  • Care partner of enrolled participant in the study
  • years of age or older
  • Able to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

URMC Neurology; 919 Westfall Rd, Building C

Rochester, New York, 14618, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 3, 2018

First Posted

October 5, 2018

Study Start

November 16, 2018

Primary Completion

June 1, 2019

Study Completion

June 2, 2019

Last Updated

December 9, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations